A Randomized Study to Evaluate the Efficacy of a Cell-Based Quadrivalent Influenza Vaccine Compared to a Non-Influenza Vaccine in Children 6 Months to 47 Months of Age
Sunday, April 27, 2025
11:15am – 11:30am HST
Location: Convention Center: 326
Airi Poder, Clinical Research Centre, Tartu, Tartumaa, Estonia; Anna Lisa T. Ong-Lim, College of Medicine - Philippine General Hospital, University of the Philippines Manila, Manila, National Capital Region, Philippines; Vince Matassa, CSL Seqirus, Melbourne, Victoria, Australia; Esther Heijnen, CSL, Amsterdam, Noord-Brabant, Netherlands; Matthew Hohenboken, CSL Seqirus, Albany, NH, United States; Deborah C. Molrine, CSL, Waltham, MA, United States
Presenting Author(s)
Deborah C. Molrine, MD MPH (she/her/hers)
Clinical Program Director CSL Waltham, Massachusetts, United States
Disclosure(s):
Deborah C. Molrine, MD MPH: CSL Seqirus (Ongoing) (Products/Services: Employment with an ineligible company, Ownership Interest including individual stocks, stock options, excluding diversified mutual funds)